Hello Heart News
22 articles
Digital health startup aims to gamify medication adherence to tackle heart disease
How Hello Heart is tackling the $300 billion healthcare problem | CTech
Maayan Cohen, CEO of Hello Heart, discussed the importance of heart health and the role of her company in addressing it. Hello Heart is a digital therapeutics company that helps people understand and improve their heart health through a heart monitor and AI algorithms within an app. The app offers tailored insights and lifestyle advice. Cohen emphasized that heart disease is the biggest problem in healthcare, with 48% of Americans having hypertension, high blood pressure, and high cholesterol. She also highlighted the economic impact of heart disease, describing it as a $300 billion problem in the U.S.
Customers
New Study Published in an American Heart Association Journal Indicates that Hello Heart's Digital Coaching App Could Contribute to Heart Health Equity
Hello Heart Announces a Groundbreaking Feature for Managing Cholesterol, Becoming the First and Only Digital Therapeutic to Tackle Whole-Heart Health
Hello Heart closes $70 million Series D to prevent heart attacks CTech
Israeli startup Hello Heart has raised $70 million in a Series D funding round led by Stripes, with participation from existing investors Maven Ventures, BlueRun Ventures, IVP, and Resolute Ventures. The companys flagship product is an FDA-cleared blood pressure monitor that works with an app, allowing users to track their blood pressure, pulse, medications, weight, and activity using AI technology. The app also provides real-time alerts for extremely high readings. The funding will be used to improve business efficiency and prepare for a potential IPO in the coming years.
Investment
Independent validation shows Hello Heart can save employers an average of $1,865 per patient
Digital heart health management solution company Hello Heart has received a Level 1 validation from the Validation Institute, the highest possible validation and credibility certification. The institute independently validated that employers saved on average $1,865 per participant per year due to Hello Heart’s AI-driven solution for heart care. The smartphone-based solution uses AI combined with behavioral science and digital coaching to support participants in lifestyle changes that can reduce their blood pressure. The technology can also predict serious heart issues before they occur. The validation was based on data from a control study with client medical claims data from self-funded employers in the years 2017-2020.
Customers
כך הטכנולוגיה משדרגת את תחום הבריאות
The article discusses how technology is upgrading the health sector, with a focus on digital health and artificial intelligence. It features an interview with Maayan Cohen, founder and CEO of Hello Heart, a company that helps people lower their blood pressure and improve heart health through digital means. The article also mentions Nvidias annual artificial intelligence conference, GTC 2021, which will be held online from November 8-11. The impact of the COVID-19 pandemic on the trend of remote health is also discussed.
CustomersPartners
מחקר חדש חושף: כך פיתוח ישראלי מסייע לאנשים הסובלים מלחץ דם גבוה
Israeli digital health startup, Hello Heart, has been found to assist people in reducing their blood pressure over time, according to a peer-reviewed study published in the prestigious scientific journal of the American Medical Association. The study followed 28,189 adults with employer-paid health insurance who used Hello Hearts technology and online treatment program. The researchers found that the more people used the startups digital treatment tool, the better their blood pressure values improved. This is the first comprehensive study published after peer review, reporting on the long-term effects of using a digital health application for blood pressure management.
Customers
Hello Heart raises $45M as it charts a broader expansion
Hello Heart, a startup offering an app-based program to help users manage their blood pressure, pulse, and medications, has raised $45 million in a series C round led by IVP, with participation from existing investors Khosla Ventures, BlueRun Ventures, and Maven Ventures. The company plans to use the funds to expand its engineering and go-to-market teams, and to track a broader range of heart conditions. The company is currently covered by more than 30 Fortune companies and was recently added to CVS Health’s digital health platform for its PBM clients.
InvestmentCustomersExpand
Survey: 65% of benefits executives expect use of remote patient monitoring to increase
Seattle-based Providence St. Joseph Health has been using creative means to manage patients’ health at home since the start of the pandemic. This includes sending home-based Covid-19 patients pulse oximeters and thermometers to share updates with nurses multiple times per day. The rise of at-home care and telehealth use has driven new interest in remote patient monitoring. A recent survey by the Employer Health Innovation Roundtable and Hello Heart found that 65% of benefits executives from 68 self-insured Fortune 500 companies plan to see remote monitoring use increase. Last year, CVS Caremark added Hello Heart to its platform for PBM clients.
CustomersPartners
Virgin Pulse Expands Homebase for Health™ With Recent Addition of 16 Health and Wellbeing Partners
Virgin Pulse, a global provider of digital health and wellbeing solutions, has announced the addition of 16 new partners to its Adaptive Partner Network. The partners will be integrated into Virgin Pulses Homebase for Health, a platform that provides a unified and personalized health and wellbeing experience for members. The new partners include Quest Diagnostics, Hello Heart, Helpsy Health, Ovia Health, Enrich, myFiTage, Aaptiv, Zeamo, Healthcare Bluebook, Headspace, SilverCloud Health, Hinge Health, Kaia Health, EX Program by Truth Initiative, Quit Genius, and dayzz. The partnership aims to address a range of urgent health issues and make health and wellbeing more accessible.
PartnersExpand
Hello Heart joins American Heart Association's Center for Health Technology & Innovation Innovators' Network with a focus on hypertension - Center for Health Technology & Innovation
Digital hypertension solution provider, Hello Heart, is set to join the American Heart Association’s Center for Health Technology & Innovation’s Innovators’ Network. The partnership aims to integrate Hello Hearts technology with the Association’s science-based health management plans to encourage the development and adoption of digital healthcare solutions. Hello Hearts solution tracks blood pressure and provides real-time coaching to users, helping them understand and improve their heart health. The company also provides an FDA-approved wireless monitor that connects to users smartphones, offering personalized, actionable insights.
Partners
CVS Caremark grows platform for PBM clients to manage digital health tools
Health Monitoring Startup Hello Heart Raises $12 Million
Palo Alto-based medtech startup Hello Heart Inc. has raised $12 million in a series B funding round led by Khosla Ventures. The company, founded in 2013 by two Israeli entrepreneurs, develops a device that tests blood pressure and blood sugar levels and helps patients monitor their health, drug intake, and physical exercise through a dedicated mobile app. This latest investment brings Hello Heart’s total funding raised to date to $23 million.
Investment
Hello Heart taps LifeScan for glucometer integration in diabetes management program
Hello Heart, a chronic disease management platform, is integrating with LifeScan OneTouch meters to expand its diabetes management program. The company, which started in hypertension, has been expanding into diabetes for the past year. The OneTouch meters are the first of several glucometer brands the company plans to support. The platform is purely digital and guarantees patient privacy, sharing data with physicians only at the patients request. The integration with LifeScan meters, which have significant market penetration, will allow patients to continue using familiar technology while benefiting from Hello Hearts digital tools.
PartnersExpand
Hello Heart pushes into crowded diabetes management space with LifeScan deal
Hello Heart, a hypertension management startup, has partnered with LifeScan to expand into the diabetes management space. Through the partnership, Hello Heart will offer its customers LifeScan’s OneTouch line of connected glucose monitors and test strips. The deal builds on an earlier feature expansion last year which allowed diabetic users to log their blood sugar levels and receive app-based suggestions about how to improve their health. The new deal with LifeScan expands the service offering to the company’s commercial employer clients who sponsor the Hello Heart program and devices for their workforce.
PartnersCustomersExpand
Hello Heart adds diabetes management, activity tracker to cardio health app
Hello Heart, a digital health company, has announced the release of a new service for diabetes management within its existing app. The app already offers tools for managing hypertension, heart rate, and cardiovascular health. The new service is part of the companys shift from a single-disease platform to one that manages prevalent chronic diseases. The app also includes tools for tracking blood pressure, weight, blood sugar levels, and activity, and features to improve medication adherence and promote healthy behavior changes. Since its launch, Hello Heart has enrolled over 80,000 patients and has several Fortune 500 clients.
CustomersExpand
Israeli health app co Hello Heart raises $9m
Israeli mobile health app startup Hello Heart has raised $9 million in a financing round led by BlueRun Ventures and with the participation of Maven Ventures, Resolute ventures and WTI. The company plans to use the new funds to expand sales operations in the US and enter new verticals in the health app market such as diabetes. It also aims to apply artificial intelligence technologies to improve clinical results. The company has offices in Palo Alto, California and its development center in Tel Aviv.
InvestmentExpand
App alert: Hello Heart
Hello Heart, a free mobile therapeutic app, has reported that 25% of its 4,000 users reduced their blood pressure by 10 points or more after six weeks of use. The app, which was launched in 2015, targets individuals with chronic heart risk and high blood pressure. It helps users manage and understand their lab results, doctor visits, and medications, and suggests personalized steps towards better health. The app is used by individuals and employees of partner companies.
CustomersPartners
Hello Heart raises $1.3M for consumer-facing lab data app
Hello Heart, a health app maker based in Redwood, California, has raised $1.3 million in a funding round. The round was led by Resolute Ventures and included participation from angel investors such as Waze CEO Noam Bardin, BlueRun Ventures Co-founder John Malloy, and Facebook Product Director Ran Makavy. The app, currently available only on iOS devices, helps patients aggregate and understand their lab data. The company plans to launch an Apple Watch app soon.
InvestmentExpand
Hello Doctor gets $700K for its personal medical records app
Hello Doctor, a startup that aims to solve the problem of interoperability among electronic health records systems at different hospitals or clinics, has raised $700K in new funding from angel investors from Facebook, Google, and a couple of pharma companies. The Tel Aviv and Palo Alto, Calif.-based companys app can pull clinical data from a number of hospitals and clinics via an API. The patient can then share the records with her current primary care doctor. The company has also integrated Apple’s HealthKit into its app, so it can begin to collect data from other apps and devices that connect to the platform and display data in iOS 8’s Health app.
InvestmentExpand
Hello Doctor Can Now Auto-Import Medical Records From Half Of U.S. Hospitals
